The tariff classification of Clindamycin Palmitate Oral Suspension in dosage form, from India
Issued December 7, 2015 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.20.0060
Headings: 3004
Product description
The subject product, Clindamycin Palmitate Oral Suspension in 75 mg/ 5 mL, is a medicinal preparation containing Clindamycin Palmitate, a semisynthetic antibiotic, as the active ingredient. It is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria.
CBP rationale
The applicable subheading for Clindamycin Palmitate Oral Suspension in dosage form will be 3004.20.0060, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments…consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Containing other antibiotics: Other: Other.
Full text
N270864 December 7, 2015 CLA-2-30:OT:RR:NC:2:238 CATEGORY: Classification TARIFF NO.: 3004.20.0060 Ms. Martha Scott NorthStar Healthcare 3300 Cork Airport Business Park, Kinsale Road Cork T12 XN72 Ireland RE: The tariff classification of Clindamycin Palmitate Oral Suspension in dosage form, from India Dear Ms. Scott: In your letter dated November 20, 2015, you requested a tariff classification ruling. The subject product, Clindamycin Palmitate Oral Suspension in 75 mg/ 5 mL, is a medicinal preparation containing Clindamycin Palmitate, a semisynthetic antibiotic, as the active ingredient. It is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria. The applicable subheading for Clindamycin Palmitate Oral Suspension in dosage form will be 3004.20.0060, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments…consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Containing other antibiotics: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Gwenn Klein Kirschner Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Clindamycin Palmitate Oral Solution in dosage form, from India
The tariff classification of Vancomycin Hydrochloride Injection in dosage form, from China
The tariff classification of Daptomycin Injection in dosage form, from China
The tariff classification of Micafungin Sodium for Injection in dosage form, from Malta
The tariff classification of Doxycycline Hyclate Injection in dosage form, from Macao
The tariff classification and country of origin of Doxorubicin Hydrochloride Liposome Injection in dosage form
The tariff classification of Vancomycin Hydrochloride for Injection in dosage form, from China
The tariff classification of Bacitracin Zinc Ointment and Zinc Oxide Ointment 20% imported in retail packs from India
The tariff classification of Sirolimus Tablets in dosage form, from India
The tariff classification of Clindamycin Phosphate 1% Lotion in dosage form, from Canada.
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →